Association of mRNA expression level of IP-10 in peripheral blood mononuclear cells with HBV-associated acute-on-chronic liver failure and its prognosis

Abstract

HBV-associated acute-on-chronic liver failure is prevalent in mainland China. The prognosis of HBV-ACLF is poor. The mortality of HBV-ACLF is approximately 80%. Therefore, a prognostic indicator was needed in order to allow us to intervene as soon as possible. The model for end-stage liver disease (MELD) scoring system is widely used to predict the prognosis of liver failure. However, the assessment is too complex to restrict its application. This study aimed to investigate the expression of IP-10 in peripheral blood mononuclear cells (PBMC), in order to explore the relationship between the expression and prognosis of patients with HBV-ACLF. The mRNA level of IP-10 in PBMCs were analyzed in 80 patients with HBV-ACLF, 40 patients with chronic hepatitis B (CHB) and 40 healthy people by fluorescent quantitative PCR. IP-10 mRNA level was significantly higher in the HBV-ACLF group than in the other two groups (P<0.01). Group with MELD score below 30 had lower IP-10 mRNA level than group with MELD score over 30 (P<0.05). The IP-10 mRNA level in PBMCs in positive group was higher than that in negative group (P<0.01). With a threshold of 0.925, the area under the receiver operating characteristic (ROC) curves was 0.815. These findings suggest that assessment of IP-10 mRNA level in the PBMCs would be helpful for evaluating the disease severity and prognosis in patients with HBV-ACLF.

Keywords

hepatitis B virus / liver failure / interferon-inducible protein-10 / mRNA / prognosis

References

[1] SarinSK, ChoudhuryA. Acute-on-chronic liver failure: terminology, mechanisms and management. Nat Rev Gastroenterol Hepatol, 2016, 13(3): 131-149 PMID: 26837712

[2] BernalW, JalanR, QuagliaA, et al. . Acute-on-chronic liver failure. Lancet, 2015, 386(10003): 1576-1587 PMID: 26423181

[3] CongYT, HuangMX. The thought of internal treatment for liver failure. J Clin Intern Med (Chinese), 2014, 31(8): 516-518

[4] AnanthakrishnanAN, McGinleyEL, SaeianK. M1868 uninsured and medicaid patients have higher mortality in acute liver failure. Gastroenterology, 2008, 134: A799-800

[5] LeifeldL, DumoulinFL, PurrI, et al. . Early up-regulation of chemokine expression in fulminant hepatic failure. J Pathol, 2003, 199(3): 335-344 PMID: 12579535

[6] BoothV, KeizerDW, KamphuisMB, et al. . The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. Biochemistry, 2002, 41(33): 10418-10425 PMID: 12173928

[7] WangJ, WangPP, XiangGJ, et al. . Relationship between the expression of IP-10 and IP-10 mRNA in peripheral blood and HBV-DNA level in patients with cirrhosis. Hepatobiliary Pancreat Dis Int, 2010, 9(3): 280-286 PMID: 20525556

[8] Liver FailureArtificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association, Severe Liver DiseasesArtificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association.. Guideline for diagnosis and treatment of liver failure. Chin J Clin Infect Dis (Chinese), 2012, 5(6): 321-327

[9] TellmannG. The E-Method: a highly accurate technique for gene-expression analysis. Nature Methods, 2006, 3: i-ii

[10] ChenLJ, LvJ, WenXY, et al. . CXC chemokine IP-10: a key actor in liver disease. Hepatol Int, 2013, 7(3): 798-804 PMID: 26201916

[11] XuCL, HaoYH, LuYP, et al. . Upregulation of toll-like receptor 4 on T cells in PBMCs is associated with disease aggravation of HBV-related acute-on-chronic liver failure. J Huazhong Univ Sci Technolog Med Sci, 2015, 35(6): 910-915 PMID: 26670445

[12] TianXL, QinB. Study of the IP-10 on virus hepatitis. Chin J Infect Dis (Chinese), 2012, 30(8): 505-508

[13] CornbergM, WiegandSB. Importance of IP-10 in hepatitis B. Antivir Ther, 2016, 21(2): 93-96 PMID: 26598599

[14] WangYD, ZhangL, ShenC, et al. . Expression of interferon gamma and interferon gamma inducible protein-10 in patients with different stages of chronic hepatitis B virus infection. Chin J Infect Dis (Chinese), 2014, 32(1): 43-47

[15] YangH, LuoYW, LiuHQ, et al. . CXCR3 and IP-10 expression in patients with chronic hepatitis B and their correlation with degree of liver inflammation and hepatic fibrosis. J Third Mil Med Univ (Chinese), 2012, 34(3): 250-253

[16] ZouY, BaoJJ, ZhouYY, et al. . Expression and significance of hepatic chemokine IP-10 mRNA in mice with fulminant hepatitis. Guangdong Yixue (Chinese), 2011, 32(2): 141-143

[17] HarveyCE, PostJJ, PalladinettiP, et al. . Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and 1obular inflammation. J Leukoc Biol, 2003, 74(3): 360-369 PMID: 12949239

[18] WangJ, ZhaoJH, WangPP, et al. . Expression of CXC chemokine IP-10 in patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int, 2008, 7(1): 45-50 PMID: 18234638

[19] GongLL, ZhaoBB, FanWF, et al. . Correlations of IFN-γ-inducible protein-10 with the risk of chronic hepatitis B and the efficacy of interferon therapy in Asians. Int J Clin Exp Pathol, 2015, 8(7): 8367-8375 PMID: 26339406 PMCID: 4555734

[20] TackeF, ZimmerrnannHW, BerresMI, et al. . Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases. Liver Int, 2011, 31(6): 840-849 PMID: 21645215

[21] SoléC, SolàE, Morales-RuizM, et al. . Characterization of inflammatory response in acute-on-chronic liver failure and relationship with Prognosis. Sci Rep, 2016, 6(1): 32-41

[22] WuZB, CaoH, LiuT, et al. . Dynamic expression profile of HBsAg according to hepatic parenchyma cells volume at different liver fibrosis stages in the immune clearance phase. Chin J Hepatol, 2012, 20: 742-745

[23] YiZQ, LuMH, XuXW, et al. . A novel prognostic score for acute-on-chronic hepatitis B liver failure. J Huazhong Univ Sci Technolog Med Sci, 2015, 35(1): 87-92 PMID: 25673199

[24] WangYD, ZhaoCY, ZhangL, et al. . Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients. Antiviral Res, 2014, 103: 51-59 PMID: 24418572

[25] WillemseSB, JansenL d, NietA, et al. . Intrahepatic IP-10 mRNA and plasma IP-10 levels as response marker for HBeAg-positive chronic hepatitis B patients treated with peginterferon and adefovir. Antiviral Res, 2016, 131: 148-155 PMID: 27155352